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Withtheincreaseduseofplant-basedcancerchemotherapy,exploringtheantiproliferativeeﬀectsofphytochemicalsforanticancer
drug design has gained considerable attention worldwide. This study was undertaken to investigate the eﬀect of walnut green husk
extracts on cell proliferation and to determine the possible molecular mechanism of extract-induced cell death by quantifying the
expression of Bcl-2, Bax, caspases-3, and Tp53. PC-3 human prostate cancer cells. In this study, we found that green husk extracts
suppressed proliferation and induced apoptosis in a dose- and time-dependent manner by modulating expression of apoptosis-
related genes. This involved DNA fragmentation (determined by TUNEL assay) and signiﬁcant changes in levels of mRNA and
the expression of corresponding proteins. An increase in expressions of Bax, caspase-3,a n dtp53 genes and their corresponding
proteins was detected using real-time PCR and western blot analysis in PC-3 cells treated with the green husk organic extracts. In
contrast,Bcl2expressionwasdownregulatedafterexposuretotheextracts.Ourdatasuggestthepresenceofbioactivecompound(s)
in walnut green husks that are capable of killing prostate carcinoma cells by inducing apoptosis and that the husks are a candidate
source of anticancer drugs.
1.Introduction
Naturalagentsandherbalproductscanboosttheactionsand
reduce the toxicity of conventional chemotherapeutic drugs
[1]. The antineoplastic eﬀects of natural agents and herbal
products may aﬀect cells by many diﬀerent mechanisms,
suchasbypreventinginitiationandpromotionofcanceroge-
nesis or inducing apoptosis. Therefore, the identiﬁcation of
activators of apoptosis may help in providing more eﬀective
strategies for cancer therapy. The walnut, Juglans regia L.,
is an important deciduous tree species found principally in
temperate areas across the world. It is cultivated throughout
eastern Asia, southern Europe, northern Africa, the United
States, western South America, and India. It is largely
consumed as part of the diet, and diﬀerent parts of plant are
often used in local folk medicine. In addition, green walnuts,
walnut shells, bark, green husks (epicarps), and leaves have
been used in the cosmetic and pharmaceutical industries
[2, 3].
Walnuts contain tocopherols and other nutrients that
may protect against prostate cancer: 75g of walnuts con-
tain 0.52mg α-tocopherols and 15.6mg γ-tocopherols [4].
Walnuts also contain ellagic acid (590μg/g) [5], which has
been shown to eﬀectively induce apoptosis and inhibit
angiogenesis [6, 7]. In addition, walnut kernels are a rich
source of unsaturated fatty acids [8]; several recent studies
have reported that consumption of 70–80g walnuts per day
reduces total and low-density lipoprotein cholesterol [9, 10].
With 543,000 new cases a year, prostate cancer is the
third most common form of cancer in the world for men,
according to the World Cancer Report 2003 [11]. Asian
populations have the world’s lowest incidence and mortality
rates of prostate cancer; however, in the last two decades,
these rates have risen rapidly in most Asian countries. At2 Evidence-Based Complementary and Alternative Medicine
present, prostate cancer is one of the principal forms of
male cancer in some Asian countries. In 2000, the age-
adjusted incidence was over 10 per 100,000 men in Japan,
Taiwan, Singapore, Malaysia, the Philippines, and Israel
[12]. According to the 1998 cancer incidence report of the
Gulf Cooperation Council countries, published by the Gulf
Center for Cancer Registration, the highest age-standardized
incidence rate of prostate cancer was in Oman and Kuwait
(10.6/100,000), followed by Bahrain (10.3/100,000), Qatar
(8.6/100,000), and the United Arab Emirates (7.1/100,000).
The lowest was in Saudi Arabia, with an age-standardized
incidence rate of 4.2/100,000 [13]; but according to a report
bytheMinistryofHealth,SaudiArabia,theage-standardized
rate of prostate cancer incidence was 3.5/100,000 in a 1999-
2000 survey [14]. Although the incidence of prostate cancer
in Saudi Arabia is low compared with other Asian countries,
the incidence appears to have risen over the last decade
[15]. Hence, with increasing longevity, prostate cancer will
becomeagrowingproblemforSaudiArabia.Evenafterthree
decades of combating breast cancer, there is still no eﬀective
cureforthisdisease.However,accordingtosomereports,the
useofcomplementaryalternativemedicinehasimprovedthe
condition of breast cancer patients [16].
Agents that suppress the proliferation of malignant cells
by enhancing apoptosis may constitute a useful mechanistic
approach to both cancer chemoprevention and chemother-
apy .H o wev er ,unfa v orablesideeﬀectsandresistancetomany
developed anticancer agents have been serious problems
[17]. Thus, there is a growing interest in the use of plant-
based compounds to develop safe, more eﬀective therapeutic
agentsin cancertreatment [18]. Since the side eﬀectsof plant
extracts are modest and well Hassan Magdyextracts from
walnut leaves inhibit the growth of PC-3 cells through apop-
tosis and to ascertain the molecular mechanism involved in
apoptosis.
2.MaterialsandMethods
2.1. Preparation of Three Organic Extracts with Increasing
Polarity. Extractions were done as described earlier [19],
with some modiﬁcations. Air-dried walnut green husks
(WNGHs) were powdered in a milling machine. Extractions
were carried out in a Soxhlet apparatus with three diﬀerent
solvents: methanol, chloroform, and n-hexane. Each organic
phase was later dried under reduced pressure to obtain the
residue.Arotaryevaporatorwasusedtoobtaintherespective
lyophilized powder/paste. Extracts were weighed and stocks
were prepared at a concentration of 100mg/mL dimethyl
sulfoxide.
2.2. Maintenance of PC-3 Cell Line. PC-3 prostate cancer
cellswereobtainedfromtheNationalCenterforCellScience,
Pune, India. The cell line was maintained and propagated in
90% Dulbecco’s modiﬁed Eagle’s medium containing 10%
fetal bovine serum and 1% penicillin/streptomycin. The cells
were cultured up to about 70% to 80% conﬂuence as an
adherent monolayer. Throughout the study, the cells were
maintained at 37◦C in a humidiﬁed atmosphere of 5%
CO2. The cells were trypsinized for harvesting after attaining
conﬂuence. Only research-grade chemicals were used in this
study.
2.3. Cell Viability Assay. According to the study design, cell
viability was assayed by means of the trypan blue exclusion
test [20] after thawing the cryopreserved vial, every time
before seeding the cells. The overall viability was over 90%.
2.4. Cell Proliferation Assay and Determination of IC50. The
Cell Titer Blue viability assay (Promega, Madison, WI, USA)
was performed to assess the toxicity of diﬀerent concen-
trations of WNGH organic extracts on PC-3 cells. The assay
was performed according to the manufacturer’s instructions.
Brieﬂy, PC-3 cells (2 × 104 cells/well) were plated in 96-well
plates and treated with 0, 5, 10, 20, 40, 80, and 160μg/mL
of all three organic extracts (methanol, chloroform, and n-
hexane) for 24 hours. Then, 40μL of the Cell Titer Blue
solution was directly added to the wells and incubated at
37◦C for 6 hours. The ﬂuorescence was recorded by means
of a 560-nm/590-nm (excitation/emission) ﬁlter set using a
Bio-Tek microplate ﬂuorescence reader (F Lx800), and the
IC50 was calculated. Quadruplet samples were run for each
concentration of the organic extracts in three independent
experiments.
2.5. Cytochemical Quantiﬁcation of Apoptosis by TUNEL As-
say. The terminal deoxynucleotidyl transferase dUTP nick-
endlabeling(TUNEL)assayisaneﬀectiveblendofmolecular
biology and morphological observation used largely for the
quantiﬁcation of apoptosis in cells [21]. In the present study,
the TUNEL assay was conducted to investigate the occur-
rence of DNA fragmentation induced by organic extracts of
RBJR. The DeadEnd TUNEL assay kit (Promega, Madison,
WI, USA) was used for studying apoptosis in a time- and
dose-dependent manner. The TUNEL assay was performed
as described earlier [22]. Brieﬂy, 2 × 104 cells/well were
cultured in six-well plates. The cells were treated with
50μg/mL and 100μg/mL of methanol, chloroform, and n-
hexaneseparatelyfor24,48,and72hours.Theculturemedia
were aspirated after the incubation period, and the cell layers
were trypsinized. The trypsinized cells were reattached on
0.01% polylysine-coated slides, ﬁxed with 4% methanol-free
formaldehyde solution, and stained according to the Dead-
End ﬂuorometric TUNEL system protocol. The stained cells
were observed using a Carl-Zeiss (Axiovert) epiﬂuorescence
microscope using a triple-bandpass ﬁlter. Green-ﬂuorescent
(FITC stain) cells were regarded as TUNEL positive; cells
with a red nucleus (PI stain) were regarded as TUNEL nega-
tive. To determine the cell count of TUNEL-positive cells,
1000 cells were counted at a magniﬁcation of ×100 in each
experiment[23].Theapoptoticcellcountsinthetreatedcells
were normalized by the control count. Each experiment was
repeated three times.
2.6. Quantiﬁcation of mRNA Level of Apoptosis-Related Genes
throughReal-Time PCR. PC-3 cellswereculturedin six-well
plates at a density of 1.5 × 105. After 24 hours of adhesion,Evidence-Based Complementary and Alternative Medicine 3
the culture media were aspirated oﬀ and the cells were treat-
ed with methanol, chloroform, and n-hexane extracts at a
concentration of 50μg/mL medium. After 24 hours of in-
cubation, the media were removed and the treated cells
were washed with ice-cold phosphate-buﬀered saline (PBS).
Fastlane Cell cDNA kit (QIAGEN, Germany) was used to
prepare cDNA directly from the cultured cells, according to
the manufacturer’s instructions. The mRNA levels of tp53,
caspase-3, bax,a n dbcl-2 as well as the reference gene, β-
actin, were assayed using gene-speciﬁc S YBR Green-based
QuantiTect Primer assays (QIAGEN, Germany). Real-time
PCR reactions and analyses were performed on an Applied
Biosystems 7500 Fast (Foster City, CA, USA).
Quantitative real-time PCR was performed in a reaction
volume of 25μL according to the manufacturer’s instruc-
tions. Brieﬂy, 12.5μL of the master mix, 2.5μLo fp r i m e r
assay(10x),and10μLoftemplatecDN A(100μg)wereadded
to each well. After brief centrifugation, the PCR plate was
subjected to 35 cycles of the following conditions: (i) PCR
activationat95◦Cfor5minutes;(ii)denaturationat95◦Cfor
5 seconds; (iii) annealing/extension at 60◦C for 10 seconds.
All samples and controls were run in triplicate on an ABI
7500 Fast Real-Time PCR System. The quantitative RT-PCR
data were analyzed by a comparative threshold (Ct) method,
and the fold inductions of the samples were compared with
the untreated samples. β-actin was used as an internal refer-
ence gene to normalize the expression of the apoptotic genes.
The Ct cycle was used to determine the expression level in
control cells and PC-3 cells treated with diﬀerent extracts
for 24 hours. The gene-expression level was then calculated
as described by Yuan et al. [24]. The results were expressed
as the ratio of the reference gene to the target gene using
the following formula: ΔCt = Ct (apoptotic genes) − Ct (β-
actin).Todeterminetherelativeexpressionlevels,thefollow-
ing formula was used: ΔΔCt = ΔCt (treated) −ΔCt (control).
Thus, the expression levels were presented as n-fold diﬀer-
ences relative to the calibrator. The value was used to plot the
expressionofapoptotic genesusingtheexpressionof2−ΔΔCt.
2.7. Apoptosis-Related Protein Expression Analysis by Immu-
noblotting. Immunoblotting analysis of apoptosis-related
proteins was performed as we described earlier [19, 23], with
a slight modiﬁcation. Brieﬂy, 2 × 105 cells/well were cultured
in six-well plates. The cells were then treated with methanol,
chloroform, and n-hexane at a concentration of 50μg/mL
for 24 hours. After treatment, the cells were collected and
washed twice with cold PBS. The cells were then lysed in lysis
buﬀer (50mM Tris-HCl, pH 7.5, 150mM NaCl, 1% Nonidet
P -40,2mMEDT A,1mMEGT A,1mMN aV O3,10mMN aF ,
1mMDTT ,1mMPMSF ,25μg/mL aprotinin, and 25μg/mL
leupeptin) and kept on ice for 30min. The lysates were then
centrifuged at 12,000×ga t4 ◦C for 20min; the supernatants
were stored at –70◦C until use. The protein concentration
was determined using the Bradford method. Aliquots of the
lysates (30μg protein) were separated by 12% SDS-PAGE
and transferred to a nitrocellulose membrane using transfer
buﬀer (192mM glycine, 25mM Tris-HC l, pH 8.8, and 20%
methanol (v/v)). After blocking with 5% nonfat dried milk,
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Figure 1:Survivalfractions.PC-3cellstreatedwithmethanol,chlo-
roform, and n-hexane extracts of WNGH, showing the IC50 against
PC-3 cells.
antibodies, followed by 30min with secondary antibodies
in milk-containing tris-buﬀered saline (TBS) and 0.5%
Tween. Anti-human p53, caspase-3, Bcl-2, Bax, and β-actin
antibodies were used at a 1:1000 dilution as the primary
antibodies, while horseradish peroxidase-conjugated horse
anti-rabbit IgG (Sigma Chemicals, USA) was used at a
1:5000 dilution as the secondary antibody. The membrane
was then exposed, and protein bands were detected using
enhanced chemiluminescence. All chemicals used during
this study were of research grade.
2.8. Statistical Analysis. All data were analyzed statistically
using PASW 18 software and represented as means ± SEM.
A t test was performed, and a P value ≤0.05 was considered
signiﬁcant.
3. Results
3.1. WNGH Extract-Induced Clonogenic Inhibition of PC-
3C e l l s .The methanol (IC50 66.72μg/mL), n-hexane (IC50
27.29μg/mL), and chloroform (IC50 91.14μg/mL) extracts
signiﬁcantly inhibited the growth of PC-3 cells (Figure 1).
Further,thesethreeextractsproducedsigniﬁcantcytotoxicity
to PC-3 cells. The IC50 values clearly indicated that n-hexane
had a higher growth-inhibiting eﬀect on PC-3 cells than n-
hexane and methanol.
3.2. Quantitative Assessment of Apoptosis by TUNEL Assay.
Todeterminetheapoptoticcellcount,PC-3cellsweretreated
with respective IC50 concentration of WNGH extracts. The
PC-3 cells treated with the extracts showed active apoptosis
in a time- and dose-dependent manner. The increase in
TUNEL-positive apoptotic cell count (out of 1000 cells
counted) over the untreated population for 24-, 48-, and
72-hour treatment was, respectively, 124 ± 11, 170 ± 16,
and 301 ± 24 for methanol; 107 ± 14, 140 ± 19, and 210 ±



































































Figure 2: Morphological observation with propidium iodide/FITC double staining by ﬂuorescence microscopy (×100). Cells were cultured
insix-wellplates.Controlcellswereuntreated(a,b).TestcellsweresubjectedtotreatmentwithIC50 ofmethanol(c,d),chloroform(e,f),and
n-hexane extracts (g, h) separately for three diﬀerent incubation periods (24, 48, and 72 hours). TUNEL assay was performed and TUNEL-
positive cells (green ﬂuorescent)—the apoptotic cells—were scored out of 1000 cells counted/treated culture of PC-3 cells. Representative
images from three independent experiments.
chloroform (Figure 3). Apoptosis was determined by micro-
scopy-based TUNEL examination (Figure 2).
3.3. Determination of Apoptosis-Related Genes by Real-Time
PCR. To investigate the molecular mechanism of WNGH
extract-induced apoptosis in PC-3 cells, the expression levels
of several apoptosis-related genes were examined. Bcl-2,
Bax, and p53 are three major proteins that are generally
involved in apoptosis. It is not known whether LE extract
induces or inhibits the expression of these genes. The relative
quantiﬁcation of tp53, caspase-3, bax,a n dbcl-2 mRNA levels
was performed.
Figure 4 summarizes the gene-expression changes of
tp53, caspase-3, bax,a n dbcl-2. WNGH extract treatment
caused a several-fold increase in the number of transcripts
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Figure 3: Score of TUNEL-positive cells. 1000 cells were counted
after each incubation period after staining with propidium iodide
and FITC; TUNEL-positive (green ﬂuorescent) cells were scored
and normalized with controls (untreated cells). Data shown are
means ± SEM for three independent experiments. MeOH Ext,
methanolextract;CHExt,chloroformextract;n-HexExt,n-hexane
extract.
genes in PC-3 cells treated with WNGH methanol extract
for 24 hours increased by 2.73 ± 0.19, 1.96 ± 0.16, and
2.87 ± 0.18, respectively. Compared with levels in untreated
controlcells,theincreaseinthemRNAlevelfortp53,caspase-
3,a n dbax was, respectively, 1.87 ± 0.11, 1.14 ± 0.11, and
2.6 ± 0.29 for cells treated with chloroform and 3.94 ±
0.24, 3.18 ± 0.38, and 4.26 ± 0.39 for cells treated with n-
hexane. A decrease in bcl2 expression was observed with
all three treatments. The lowest value of expression was
found in n-hexane-treated PC-3 cells (–3.11 ± 0.39); bax
expression signiﬁcantly increased in WNGH extract-treated
cells (Figure 4), which indicates that the WNGH-extract
treatment induced apoptosis by shifting the Bax:Bcl-2 ratio
in favor of apoptosis.
3.4. Determination of Apoptosis-Related Proteins by Protein
Immunoblotting. Protein immunoblotting results indicated
that compared with controls, the expression of Tp53,
Caspase-3, and Bax proteins was higher in n-hexane-
treated PC-3 cells followed, respectively, by those treated




Agents suppressing the proliferation of malignant cells by
enhancing apoptosis may constitute a useful mechanistic
approach to both cancer chemoprevention and chemother-
apy. Many anticancer agents have been developed, but





















Figure 4: Fold change in expression of mRNA of apoptosis-
related genes against controls over 24 hours. Real-time polymerase
chain reaction analysis of apoptosis-related genes showed that
tp53, caspase-3,a n dbax were up-regulated in cells treated with all
three extracts, but bcl-2 was downregulated. Data represented are

























































Figure 5: Protein immunoblotting/western blotting of apoptosis-
related proteins. Protein-expression study showed upregulation of
Tp53, Caspase-3, and Bax but downregulation of Bcl-2.
There is, therefore need for more eﬀective anticancer agents.
Over the past few decades, screening medicinal plants and
theirparts foranticancerproperties has developed as amajor
ﬁeld of interest in medicine and chemistry. In our earlier
study, we demonstrated that organic extracts of Juglans
regia L. root bark are able to inhibit cell proliferation and6 Evidence-Based Complementary and Alternative Medicine
induce apoptosis in MDA-MB 231 breast cancer cells [19].
In the present study, the anticancer property of WNGHs was
evaluated in PC-3 cells. WNGHs were extracted using diﬀer-
ent organic solvents (methanol, chloroform, and n-hexane).
The results demonstrate that WNGHs suppressed the
proliferation of PC-3 cells, and apoptosis was induced in a
dose- and time-dependent manner. The IC50 values clear-
ly indicated that the n-hexane extract had a much more
potent eﬀect on PC-3 cells than the chloroform and meth-
anol extracts (Figure 2). Walnuts contain various com-
pounds—omega-3 fatty acids, phytosterols, polyphenols,
carotenoids,andmelatonin—thatmayinhibitcancergrowth
anddecreasetumorcellproliferation[25].Juglone(5-hydro-
xy-1,4-naphthoquinone) is a chemical present in walnut
trees that can be toxic at various levels [26], and it has
antitumor activities against melanoma cells. Induction of
oxidative stress, cell membrane damage, and a clastogenic
action contribute to the cytotoxic eﬀect of juglone [27].
Using transmission electron microscopy, Ji et al. have also
reported the typical morphological changes of apoptosis,
such as chromatin condensation, margination against the
nuclearenvelopeandtheformationofapoptoticbodies,after
juglone treatment [28].
To understand the potential antitumor mechanisms of
WNGH, the expression of pro- and antiapoptotic genes
was investigated in the present study. We found decreased
expressionof Bcl-2mRNAandprotein,butincreasedexpres-
sion of Bax, caspase3,a n dp53 mRNA and protein; therefore,
the Bax:Bcl-2 ratio was elevated. In addition, the expression
of p53, caspase-3, and Bax mRNA and proteins was highest
in n-hexane-treated PC-3 cells followed, respectively, by
those treated with methanol and chloroform compared with
controls. However, Bcl-2 mRNA and protein were downreg-
ulated in PC-3 cells treated with all three extracts compared
with controls. The data presented in this study suggest that
WNGH-induced apoptosis is mediated by the death receptor
and mitochondrial apoptotic pathways, as demonstrated by
increased expression levels of caspase-3 after WNGH treat-
ment.
These pro- and antiapoptotic proteins are the principal
regulators of the intrinsic pathway of apoptosis [29]. Pre-
vious reports have shown that the ratio of Bax to Bcl-2
determines, in part, the susceptibility of cells to death signals
[30]. In the present study, Bcl-2 expression was signiﬁcantly
inhibited, whereas the expression of Bax, Tp53, and caspase-
3 markedly increased in all extract treatments.
WNGH extract may induce apoptosis through p53,
through the downregulation of Bcl-2 and Mdm2,a n d
through upregulation of Bax. The Bcl-2 family is one of the
most important classes of regulators involved in the intrinsic
pathway. The functions of Bax and Bcl-2 are known to be
upstream of caspases that regulate apoptosis promoted by
diﬀerent stimuli [31].
The possible mechanism by which p53 regulates apop-
tosis involves activating the mitochondria-regulated death
pathway by elevating gene expression of proapoptosis genes
in the Bcl-2 family and suppressing the expression of anti-
apoptotic genes [32, 33]. p53 protein interacts with Bcl-2
to enhance Bax-promoted outer-mitochondrial membrane
permeabilization,andp53isadirecttranscriptionalactivator
of the Bax gene [34, 35].
Increased expression of p53 induces an increase in the
Bax:Bcl-2 ratio, resulting in cytochrome-c, caspase activa-
tion, and, ultimately, apoptosis. One possible mechanism
by which Bax m a yf u n c t i o ni nt h ep53-mediated cell-
death pathway is through the activation of caspases: p53-
mediated activation of caspase-3 is dependent on Bax [36].
Bax is required for caspase activation after the potassium
withdrawal-enhanced cell death of cerebellar granule neu-
rons [37]. Furthermore, Bax overexpression can promote
caspaseactivationinneuronalcells[38,39].Ourdatasuggest
that WNGH extract may induce cell apoptosis mediated by
p53. Apoptosis is also the result of death receptor-dependent
(extrinsic) or death receptor-independent (intrinsic or mito-
chondrial) mechanisms [40].
By inducing the release of mitochondrial cytochrome
c, p53 m a yb ea b l et oa c t i v a t ee ﬀector caspases, including
caspase-3. WNGH extract may induce apoptosis mediated by
p53throughthedownregulationofBcl-2andupregulationof
Bax. WNGH extract has shown antitumor eﬀects on breast
cancer cells, and the present results suggest that WNGH
extracts can induce p53-mediated apoptosis via modulation
of the Bax:Bcl-2 ratio. Protein-expression data are needed to
conﬁrm the changes observed at the mRNA level.
Based on the bioactivity of these compounds from
WNGHs, their identiﬁcation and determination will play
an important role in the safe, eﬀective use of WNGHs for
pharmaceutical purpose. Therefore, it is necessary to devel-
op an analytical method to identify and determine these
compounds.
According to present knowledge, WNGHs contain a bat-
tery of bioactive compounds of diﬀerent chemical types, in-
cluding ﬂavanoids, naphthoquinones, diarylheptanoids, tri-
terpenes, phenol acid, sterol, and lipid substances. The total
phenol content in WNGH extracts may diﬀer according to
the solvent used for extraction. However, all three organic
extractsusedinthepresentstudywereabletoinduceapopto-
sis owing to their respective bioactive compounds; however,
the higher toxic activity of n-hexane extract suggests the
presence of a greater amount of bioactive compounds. Fur-
therstudyisrequiredtocharacterizeWNGHorganicextracts
and to identify the molecules responsible for this bioactivity.
On the other hand, the potential observed with WNGH
organic extracts may lead to the valorization of a by-product
that currently has scarce use.
In conclusion, the present study demonstrated that the
WNGH extract inhibited cancer cell proliferation via the
induction of apoptosis. WNGH extract-induced MCF-7 cell
death was shown to be due to apoptosis, as demonstrated
by the induction of caspase-3 activity and the observation of
cells containing fragmented nuclei and DNA.
As far we know, we have demonstrated for the ﬁrst time
that the apoptotic response is associated with upregulation
of Bax, downregulation of Bcl-2, and caspase activation.
Therefore, we suggest that WNGH extract may be a good
source of promising molecules in cancer chemoprevention
or chemotherapy. These results indicate that the WNGH
extract has an anticancer activity in vitro. Further studiesEvidence-Based Complementary and Alternative Medicine 7
are necessary to determine the molecular mechanisms of
the active components and to evaluate the potential in vivo
anticancer activity of the extract.
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